16 listed pharmaceutical companies “concentrated suspensionâ€
Some studies have pointed out that major changes in industrial policies and standards such as the new version of GMP reforms, changes in bidding policies, and the liberalization of private hospital policies are spurring a new wave of mergers and acquisitions with the aim of product (technical) mergers and acquisitions in the pharmaceutical industry. 16 listed pharmaceutical companies have experienced the phenomenon of suspension of major events, which is generally considered by the industry to be related to the industry's upcoming large-scale reorganization mergers and acquisitions.
As of March 19, many listed pharmaceutical companies such as China Resources Wandong, Qianshan Pharmaceutical Machinery, Tiger Pharmaceuticals, Connbay Pharmaceuticals, Fengyuan Pharmaceutical, Yuexiu Medical, and Haixiang Pharmaceuticals were still in the suspension phase. At the beginning of March, there were 14 pharmaceutical companies temporarily suspended trading. Take China Resources Wandong as an example, the company suspended its license because the actual controller China Resources General Corporation planned to strategically withdraw its medical device business, and Haixiang Pharmaceuticals had to start a self-help reorganization due to the sluggish cycle of APIs.
In addition, the impact of the new GMP reform on mergers and acquisitions in the industry is also emerging. Connehbe had to postpone the resumption of trading due to the impact of the new GMP reform on the target company. According to the information previously disclosed by Connbay, the major asset restructuring plan of the company was the purchase of equity assets of a domestic pharmaceutical company.
Changes in Policy Criteria Impact on Industry Expectations In the eyes of some companies in the industry, the introduction of major industry policies and the improvement of admission standards are changing the industry’s previous expectations of the pharmaceutical industry. This kind of expected change is the objective reason why the listed pharmaceutical companies currently have major problems.
As of December 31, 2013, there were a total of 1,319 aseptic pharmaceutical manufacturing companies in the country, and 60.3% had passed the new GMP certification. In other words, nearly 40% of aseptic drug manufacturers have not yet passed GMP certification, and in 2014 they have been put into production.
Other dosage forms of enterprises and production workshops are also required to meet the new GMP requirements by December 31, 2015. The results of this policy change show that the country intends to increase the concentration of aseptic drugs, and the increase in concentration will inevitably be conducive to the survival of high-quality enterprises, and the merger and reorganization opportunities among them are expected to show up at the end of 2014. .
(1) It is used as a variety of industrial metal parts that like electronic component, auto spare parts,
home appliance, industrial equipment...etc.Material based on SPCC and SGCC, stainless steel, aluminum alloy5052, 6063, 6061, Stainless steel 304, 316, 201, carbon steel,etc.
(2) Software for specification drawings: Pro/E, Auto CAD, PDF, IGES/IGS, STP/STEPS, X_T, DXF etc..
(3) High precision as following: Carbon steel: 0.5mm~16mm,Stainless steel: 1mm~8mm,Aluminum alloy: 1mm~8mm,Brass: 1mm~4mm.
Accuracy: positioning accuracy: ±0.03mm, Repeated positioning accuracy: ±0.02mm
(4) Main poduction machine: Laser Cutting Machine, CNC punching machine, welder, CNC bending machine
(5) Surface treatment: Polishing, grinding, gavanized, powder coating, nickel, zinc, chrome, silver, gold plating etc.
(6) For packing: A variety of packing methods can be used according to customers' requirement, such as carton , wood box, wood crate and pallet etc.
Copper Laser Cutting
Copper Laser Cutting,Small Laser Cutter,Custom Copper Laser Cutting,Copper Laser Cutting Services
Nanpi Jian Tong Hardware Manufacturing Co., Ltd. , http://www.jiantongstamping.com